| Primary information |
|---|
| ID | antitb_1816 |
| Peptide Name | ubiquitin-derived peptide Ub2 |
| Sequence | STLHLVLRLRGG |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Length | 12 |
| Chirality | L |
| Nature | Cationic |
| Source | Protein Derived |
| Origin | Ubiquitin derived |
| Species | Mycobacterium smegmatis |
| Strain | Mycobacterium smegmatis mc2155 |
| Inhibition Concentartion | MIC = 50 μM |
| In vitro/In vivo | In vitro |
| Cell Line | None |
| Inhibition Concentartion | NA |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | Micellar aggregate channel model |
| Target | Cytoplasmic membrane |
| Combination Therapy | NA |
| Other Activities | NA |
| Pubmed ID | 23173767 |
| Year of Publication | 2012 |
| 3-D Structure | NA |